New clue to aggressive brain tumors

Scientists at the School of Medicine have identified a biological marker that may help predict overall survival of people with deadly brain tumors. The marker is made by noncancerous cells known as monocytes (pictured in brown).

Pediatric tumors traced to stem cells in developing brain

​Stem cells that come from a specific part of the developing brain help fuel the growth of brain tumors caused by an inherited condition, researchers, including David H. Gutmann, MD, PhD, at Washington University School of Medicine in St. Louis report.

WUSTL Neurofibromatosis Center to host symposium May 4

The Washington University Neurofibromatosis (NF) Center at will host its first research symposium May 4. The event will focus on clinical and basic science research on neurofibromatosis 1, an inherited condition that increases risk of brain tumors in children and adults.

Brain scans reveal drugs’ effects on attention

Scientists have developed a way to evaluate new treatments for some forms of attention deficit disorder. Working in mice, researchers at the School of Medicine showed that they can use brain scans to quickly test whether drugs increase levels of dopamine. The same group found that raising dopamine levels in mice alleviates attention deficits caused by neurofibromatosis type 1 (NF1), a condition that affects more than 100,000 people in the United States.